rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Alpha Tau Medical Ltd. -

DRTS · Nasdaq

Health CareMedical DevicesLeading

DRTS stood above a rising 150-day average in 52 of the last 52 weekly readings, every one of them. It is 11.1% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
52 in a row
Industry in uptrend
27% -7 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$3.1M
Officials’ trades on record
0
Institutions holding
71 (+20)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 52 of 52 weeks.

20 Apr – 19 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.9M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months9
Buyers · sellers0 · 1
WhoDidSharesTraded
Raphi LevyChief Financial Officersold2,871at $15.0021 Aug 2026filed 25 Aug 2026
Raphi LevyChief Financial Officersold17,730at $14.0011 Aug 2026filed 12 Aug 2026
Raphi LevyChief Financial Officersold2,270at $14.006 Jul 2026filed 7 Jul 2026
Raphi LevyChief Financial Officersold17,873at $13.002 Jul 2026filed 6 Jul 2026
Raphi LevyChief Financial Officersold2,127at $13.021 Jul 2026filed 2 Jul 2026
Raphi LevyChief Financial Officersold20,000at $12.0030 Jun 2026filed 1 Jul 2026
Raphi LevyChief Financial Officersold4,222at $11.0025 Jun 2026filed 26 Jun 2026
Raphi LevyChief Financial Officersold15,778at $11.0025 Jun 2026filed 26 Jun 2026
Raphi LevyChief Financial Officersold15,000at $9.4723 Jun 2026filed 25 Jun 2026
Raphi LevyChief Financial Officersold2,500at $10.0023 Jun 2026filed 25 Jun 2026
Raphi LevyChief Financial Officersold17,500at $10.903 Jun 2026filed 4 Jun 2026
Raphi LevyChief Financial Officersold15,000at $10.763 Jun 2026filed 4 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders71+20 on the quarter
New · exited25 · 5
Reported value$99.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Gem Investment Advisors, LLCadded · filed 11 Aug 20261,434,476$18.0M+1,320,740+1161.2%
HighTower Advisors, LLCunchanged · filed 5 Aug 2026874,994$11.0M00.0%
BOOTHBAY FUND MANAGEMENT, LLCnew · filed 14 Aug 2026773,481$9.7M+773,481
Aquamarine Financial (Cayman) Ltdunchanged · filed 12 Aug 2026721,501$9.1M00.0%
Pier Capital, LLCnew · filed 5 Aug 2026691,939$8.7M+691,939
UBS Group AGadded · filed 13 Aug 2026642,263$8.1M+355,575+124.0%
Apella Capital, LLCunchanged · filed 8 Jul 2026382,284$4.9M00.0%
ARK Investment Management LLCreduced · filed 14 Aug 2026277,086$3.5M-15,048−5.2%
POLEN CAPITAL MANAGEMENT LLCnew · filed 4 Aug 2026220,751$2.8M+220,751
Focus Partners Wealthadded · filed 12 Aug 2026184,726$2.3M+152,461+472.5%
31 Mar 2023 – 30 Jun 2026
174369Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Raphi Levy Company insiderChief Financial Officer · last 21 Aug 20260 · 9

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
ATRC AtriCureLeading+47%
HTFL HeartflowLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-44.4%
Share count trendFY 2025 · to 31 Dec 202525.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$12.2M
Free cash flowFY 2025 · to 31 Dec 2025−$32.8M

Analyst forecasts

No analyst forecasts yet.